Cross-over study of influence of oral vitamin C supplementation on inflammatory status in maintenance hemodialysis patients

BMC Nephrology

Volumn 14, Issue 1, 2013, Pages

  Zhang, Kun Ying ^a,b,c   Li, Yinhui ^e   Cheng, Xuyang ^a,b,c   Liu, Li ^a,b,c   Bai, Wenying ^f   Guo, Weiya ^g   Wu, Leiyun ^h   Zuo, Li ^a,b,c,d  

^a PEKING UNIVERSITY FIRST HOSPITAL   (China)

^b PEKING UNIVERSITY   (China)

^c BEIJING HOSPITAL   (China)

^d PEKING UNIVERSITY PEOPLE S HOSPITAL   (China)

^e PR China   (China)

^f Daxing District People's Hospital   (China)

^g Guangwai Hospital   (China)

^h Beijing No 2 Hospital   (China)

Author keywords

Hemodialysis; Inflammation; Vitamin C

Indexed keywords

ALBUMIN; ASCORBIC ACID; C REACTIVE PROTEIN; HEMOGLOBIN; PREALBUMIN;

ADULT; AGED; ARTICLE; ASCORBIC ACID DEFICIENCY; CROSSOVER PROCEDURE; FEMALE; HEMODIALYSIS PATIENT; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; INFLAMMATION; MAJOR CLINICAL STUDY; MALE; VITAMIN BLOOD LEVEL; VITAMIN SUPPLEMENTATION;

ADMINISTRATION, ORAL; ASCORBIC ACID; CHINA; COMBINED MODALITY THERAPY; COMORBIDITY; CROSS-OVER STUDIES; DIETARY SUPPLEMENTS; FEMALE; HUMANS; MALE; MIDDLE AGED; NEPHRITIS; PREVALENCE; RENAL DIALYSIS; RENAL INSUFFICIENCY, CHRONIC; RISK FACTORS; TREATMENT OUTCOME;

EID: 84887339818     PISSN: None     EISSN: 14712369     Source Type: Journal    
DOI: 10.1186/1471-2369-14-252     Document Type: Article

References (37)

1. Clinical epidemiology of cardiovascular disease in chronic renal disease. Foley RN, Parfrey PS, Sarnak MJ, Am J Kidney Dis 1998 32 5 Suppl 3 112 S119 9820470
2. C-reactive protein predicts all-cause and cardiovascular mortality in hemodialysis patients. Yeun JY, Levine RA, Mantadilok V, Kaysen GA, Am J Kidney Dis 2000 35 3 469 476 10.1016/S0272-6386(00)70200-9 10692273 (Pubitemid 30124077)
3. Cardiovascular risk in uraemic patients-is it fully explained by classical risk factors? Zoccali C, Nephrol Dial Transplant 2000 15 4 454 457 10.1093/ndt/15.4.454 10727537 (Pubitemid 30160649)
4. C-reactive protein as an outcome predictor for maintenance hemodialysis patients. Owen WF, Lowrie EG, Kidney Int 1998 54 2 627 636 10.1046/j.1523-1755. 1998.00032.x 9690231 (Pubitemid 28357427)
5. Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men. Ridker PM, Cushman M, Stampfer MJ, Tracy RP, Hennekens CH, N Engl J Med 1997 336 14 973 979 10.1056/NEJM199704033361401 9077376 (Pubitemid 27152782)
6. Inflammation enhances cardiovascular risk and mortality in hemodialysis patients. Zimmermann J, Herrlinger S, Pruy A, Metzger T, Wanner C, Kidney Int 1999 55 2 648 658 10.1046/j.1523-1755.1999.00273.x 9987089 (Pubitemid 29082891)
7. Convective and diffusive losses of vitamin C during haemodiafiltration session: a contributive factor to oxidative stress in haemodialysis patients. Morena M, Cristol JP, Bosc JY, Tetta C, Forret G, Leger CL, Delcourt C, Papoz L, Descomps B, Canaud B, Nephrol Dial Transplant 2002 17 3 422 427 10.1093/ndt/17.3.422 11865087 (Pubitemid 34211138)
8. Plasma ascorbic acid in patients undergoing chronic haemodialysis. Wang S, Eide TC, Sogn EM, Berg KJ, Sund RB, Eur J Clin Pharmacol 1999 55 7 527 532 10.1007/s002280050668 10501823 (Pubitemid 29446554)
9. Oral vitamin C supplementation in hemodialysis patients and its effect on the plasma level of oxidized ascorbic acid and Cu/Zn superoxide dismutase, an oxidative stress marker. Washio K, Inagaki M, Tsuji M, Morio Y, Akiyama S, Gotoh H, Gotoh T, Gotoh Y, Oguchi K, Nephron Clin Pract 2008 109 2 49 c54 10.1159/000137628 18544955
10. Ascorbic acid depletion during hemodialysis. Sullivan JF, Eisenstein AB, JAMA 1972 220 13 1697 1699 10.1001/jama.1972.03200130029006 5067604
11. C-reactive protein and anti-Chlamydia pneumoniae antibodies as risk factors of cardiovascular death in incident patients on peritoneal dialysis. Paniagua R, Frias Y, de Ventura MJ, Rodriguez E, Hurtado ME, Alcantara G, Vazquez R, Ortiz R, Salcedo M, Rios ME, et al. Perit Dial Int 2003 23 2 132 137 12713079 (Pubitemid 36410854)
12. Low levels of vitamin C in dialysis patients is associated with decreased prealbumin and increased C-reactive protein. Zhang K, Liu L, Cheng X, Dong J, Geng Q, Zuo L, BMC Nephrol 2011 12 18 10.1186/1471-2369-12-18 21548917
13. Effects of oral vitamin C supplementation on oxidative stress and inflammation status in haemodialysis patients. Fumeron C, Nguyen-Khoa T, Saltiel C, Kebede M, Buisson C, Drueke TB, Lacour B, Massy ZA, Nephrol Dial Transplant 2005 20 9 1874 1879 10.1093/ndt/gfh928 15972322 (Pubitemid 41222602)
14. Antioxidant therapy does not ameliorate oxidative stress and inflammation in patients with end-stage renal disease. Kamgar M, Zaldivar F, Vaziri ND, Pahl MV, J Natl Med Assoc 2009 101 4 336 344 19397224
15. Analysis of a form of oxidative DNA damage, 8-hydroxy-2′- deoxyguanosine, as a marker of cellular oxidative stress during carcinogenesis. Kasai H, Mutat Res 1997 387 3
16. Association between vitamin C deficiency and dialysis modalities. Zhang K, Dong J, Cheng X, Bai W, Guo W, Wu L, Zuo L, Nephrology (Carlton) 2012 17 5 452 457 10.1111/j.1440-1797.2012.01595.x 22404236
17. Adult scurvy. Reuler JB, Broudy VC, Cooney TG, JAMA 1985 253 6 805 807 10.1001/jama.1985.03350300093027 3968818 (Pubitemid 15167017)
18. Vitamin C deficiency and secondary hyperparathyroidism in chronic haemodialysis patients. Richter A, Kuhlmann MK, Seibert E, Kotanko P, Levin NW, Handelman GJ, Nephrol Dial Transplant 2008 23 6 2058 2063 10.1093/ndt/gfn084 18353890 (Pubitemid 351768180)
19. Effect of hemodialysis on total antioxidant capacity and serum antioxidants in patients with chronic renal failure. Jackson P, Loughrey CM, Lightbody JH, McNamee PT, Young IS, Clin Chem 1995 41 8 Pt 1 1135 1138 7628087
20. Secondary oxalosis: a cause of delayed recovery of renal function in the setting of acute renal failure. Alkhunaizi AM, Chan L, J Am Soc Nephrol 1996 7 11 2320 2326 8959621 (Pubitemid 27465935)
21. Knowledge of dietary restrictions and the medical consequences of noncompliance by patients on hemodialysis are not predictive of dietary compliance. Durose CL, Holdsworth M, Watson V, Przygrodzka F, J Am Diet Assoc 2004 104 1 35 41 10.1016/j.jada.2003.10.016 14702581 (Pubitemid 38058296)
22. Deficiencies of vitamins in CAPD patients: the effect of supplementation. Boeschoten EW, Schrijver J, Krediet RT, Schreurs WH, Arisz L, Nephrol Dial Transplant 1988 3 2 187 193 3140085
23. Determination of plasma ascorbic acid by HPLC: method and stability studies. Wang S, Schram IM, Sund RB, Eur J Pharm Sci 1995 3 4 231 239 10.1016/0928-0987(95)00011-2
24. Implication of an increased oxidative stress in the formation of advanced glycation end products in patients with end-stage renal failure. Miyata T, Wada Y, Cai Z, Iida Y, Horie K, Yasuda Y, Maeda K, Kurokawa K, van Ypersele DSC, Kidney Int 1997 51 4 1170 1181 10.1038/ki.1997.160 9083283 (Pubitemid 27186543)
25. Low environmental pH is responsible for the induction of nitric-oxide synthase in macrophages. Evidence for involvement of nuclear factor-kappaB activation. Bellocq A, Suberville S, Philippe C, Bertrand F, Perez J, Fouqueray B, Cherqui G, Baud L, J Biol Chem 1998 273 9 5086 5092 10.1074/jbc.273.9.5086 9478960 (Pubitemid 28108668)
26. Relations between malnutrition-inflammation-atherosclerosis and volume status. The usefulness of bioimpedance analysis in peritoneal dialysis patients. Demirci MS, Demirci C, Ozdogan O, Kircelli F, Akcicek F, Basci A, Ok E, Ozkahya M, Nephrol Dial Transplant 2011 26 5 1708 1716 10.1093/ndt/gfq588 20921295
27. Inflammation in end-stage renal disease: sources, consequences, and therapy. Stenvinkel P, Alvestrand A, Semin Dial 2002 15 5 329 337 10.1046/j.1525-139X.2002.00083.x 12358637
28. Protective effect of vitamin C on 8-hydroxy-2′-deoxyguanosine level in peripheral blood lymphocytes of chronic hemodialysis patients. Tarng DC, Liu TY, Huang TP, Kidney Int 2004 66 2 820 831 10.1111/j.1523-1755.2004.00809.x 15253739 (Pubitemid 38982027)
29. Hemoglobin and plasma vitamin C levels in patients on peritoneal dialysis. Finkelstein FO, Juergensen P, Wang S, Santacroce S, Levine M, Kotanko P, Levin NW, Handelman GJ, Perit Dial Int 2011 31 1 74 79 10.3747/pdi.2009.00154 20558814
30. Serum ascorbic acid and protein calorie malnutrition in continuous ambulatory peritoneal dialysis patients. Lee EJ, Myint CC, Tay ME, Yusuf N, Ong CN, Adv Perit Dial 2001 17 219 222 11510280
31. Effect of intravenous ascorbic acid in hemodialysis patients with EPO-hyporesponsive anemia and hyperferritinemia. Attallah N, Osman-Malik Y, Frinak S, Besarab A, Am J Kidney Dis 2006 47 4 644 654 10.1053/j.ajkd.2005.12. 025 16564942
32. Vitamin C plasma level and response to erythropoietin in patients on maintenance haemodialysis. Deicher R, Ziai F, Habicht A, Bieglmayer C, Schillinger M, Horl WH, Nephrol Dial Transplant 2004 19 9 2319 2324 10.1093/ndt/gfh260 15299098 (Pubitemid 39214128)
33. Randomized, crossover study of the effect of vitamin C on EPO response in hemodialysis patients. Keven K, Kutlay S, Nergizoglu G, Erturk S, Am J Kidney Dis 2003 41 6 1233 1239 10.1016/S0272-6386(03)00356-1 12776276 (Pubitemid 36637979)
34. Interrelationship of dietary ascorbic acid and iron on the tissue distribution of ascorbic acid, iron and copper in female guinea pigs. Smith CH, Bidlack WR, J Nutr 1980 110 7 1398 1408 7381603 (Pubitemid 10022468)
35. Correction of subclinical ascorbate deficiency in patients receiving dialysis: effects on plasma oxalate, serum cholesterol, and capillary fragility. Tomson CR, Channon SM, Parkinson IS, McArdle P, Qureshi M, Ward MK, Laker MF, Clin Chim Acta 1989 180 3 255 264 10.1016/0009-8981(89)90007-7 2743578 (Pubitemid 19098855)
36. Vitamin C intoxication and hyperoxalemia in chronic hemodialysis patients. Pru C, Eaton J, Kjellstrand C, Nephron 1985 39 2 112 116 10.1159/000183353 3974772 (Pubitemid 15178719)
37. Rapid mobilization of ferritin iron by ascorbate in the presence of oxygen. Bienfait HF, van den Briel ML, Biochim Biophys Acta 1980 631 3 507 510 10.1016/0304-4165(80)90028-8 7407258 (Pubitemid 10022736)